116 related articles for article (PubMed ID: 17892845)
1. Correlates of immune protection and the development of a human immunodeficiency virus vaccine.
Letvin NL
Immunity; 2007 Sep; 27(3):366-9. PubMed ID: 17892845
[TBL] [Abstract][Full Text] [Related]
2. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
Pantaleo G; Koup RA
Nat Med; 2004 Aug; 10(8):806-10. PubMed ID: 15286782
[TBL] [Abstract][Full Text] [Related]
3. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
4. [Development of an AIDS vaccine: status report].
Girard MP
Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
[TBL] [Abstract][Full Text] [Related]
5. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
Masopust D
J Intern Med; 2009 Jan; 265(1):125-37. PubMed ID: 19093965
[TBL] [Abstract][Full Text] [Related]
6. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
7. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
Leligdowicz A; Rowland-Jones S
Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
[TBL] [Abstract][Full Text] [Related]
8. Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus.
Friedrich TC; Watkins DI
Curr Opin HIV AIDS; 2008 May; 3(3):393-8. PubMed ID: 19372996
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
10. IgM, not IgG, a key for HIV vaccine.
Yang QE
Vaccine; 2009 Feb; 27(9):1287-8. PubMed ID: 19146899
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
12. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
13. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
14. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.
Guerbois M; Moris A; Combredet C; Najburg V; Ruffié C; Février M; Cayet N; Brandler S; Schwartz O; Tangy F
Virology; 2009 May; 388(1):191-203. PubMed ID: 19345390
[TBL] [Abstract][Full Text] [Related]
16. [Vaccinations of HIV-infected travelers].
Couzigou C; Voyer C; Shaghaghi CK; Bourée P; Vittecoq D
Med Mal Infect; 2009 Jan; 39(1):21-8. PubMed ID: 18723304
[TBL] [Abstract][Full Text] [Related]
17. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs).
Kotwal GJ
Vaccine; 2008 Jun; 26(24):3055-8. PubMed ID: 18241960
[TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
Cohen J
Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
[No Abstract] [Full Text] [Related]
20. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
White A
Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
